Wollongong-based online news outlet covering Australia and beyond. If you have anything newsworthy - a story, video or picture to share with us, please email us. On November 5, 2026, the New England Journal of Medicine published a study on the long-term efficacy…
Wollongong-based online news outlet covering Australia and beyond. If you have anything newsworthy - a story, video or picture to share with us, please email us. Analyzing a massive collection of data from 150,000 patient tumor samples, researchers have identified T cell…
PharmaDispatch Vaccines dominate public health spending but prevention investment slips Government spending on organised immunisation reached $2.59 billion in 2024-25, almost half of Australia's public health expenditure, according to new figures from the Australian Institute of Health and Welfare. … Medicines industry faces…
Every year, the World Health Organization (WHO) and UNICEF estimate what share of children in each country get each routine vaccine. Their Estimates of National Immunization Coverage cover vaccines against 13 diseases, from measles to rotavirus, in 195 countries since 1980. They start…
FDA-approved GLP-1s at their lowest prices. See if you qualify See all Weight Loss Lose weight with GLP-1s Learn about the Ro Body membership Tadalafil (Generic of Cialis) Megan Fox for Ro Sparks See all men's health Sperm Kit Member…
What Does TELUS (TSX:T) Gain From Ratifying Its New Union Agreement? The central outcome was that gains from adding ATR inhibition were concentrated in specific tumour types and combinations rather than spread evenly. For a small research company, that kind…
Most medical data piles up around sickness. Hospitals collect scans and samples when something goes wrong, which leaves researchers with plenty of disease examples and a thin picture of what normal looks like. A healthy human tissue atlas flips that.
Rate Decision Day: How Is Zip Co (ASX:ZIP) Squaring Up? Software Bruises: Where Does Iress (ASX:IRE) Turn Next? Recruitment for XanaMIA closed earlier, and all patient visits are complete. The company confirmed in late October that the database…
The FDA has accepted uniQure’s application for AMT-130, an experimental gene therapy for Huntington’s disease, and set a May 2027 decision date. Here’s what this milestone means, and what still needs to happen. AMT-130 is a gene therapy designed to lower…
Has Gold Bottomed? What It Means for ASX 200's Ramelius (ASX:RMS) Unhedged and Exposed: Why Is ASX 200's Capricorn (ASX:CMM) on Watch? The month brings several scheduled events that could shape how the market views Immutep. The late-breaking poster…
Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.
An article joins this feed when it matches these terms. Each one is also a search of its own.